GeekWire

FEBRUARY 8, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology , a Seattle-based biotech startup led by Isilon co-founder Sujal Patel , is the latest company to go public using a special purpose acquisition company, or SPAC. Nautilus Photo).

Biotechnology 145

Biotechnology .Net Groups Company 145

GeekWire

JUNE 9, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

Biotechnology 118

Biotechnology Analysis Research Engineering 118

Trends in the Living Networks

AUGUST 11, 2022

Presentations and projects find her speaking to her interests, the importance of safe equanimity and its impact on the nexus of biotechnology and cultural design. She is a future thinker who specializes in the field of management and has launched more than 100 products, netting $18 billion in sales. Twitter: @BlakeMichelleM.

Study 148

Study Research Trends Education 148